What's new

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 29, Status: Authorised

Jun 3, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 29, Status: Authorised
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 29, Status: Authorised
Read More

Tags:

Previous Article

Patients and consumers

Next Article

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commissio...

Related Posts

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Veterinary medicines European public assessment report (EPAR): Nobilis Multriva IBm+ND+Gm+REOm+EDS, Avian infectious bronchitis, Newcastle disease, avian infectious bursal disease, avian reovirus and egg drop syndrome virus vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report ...

May 16, 2025  0

Human medicines European public assessment report (EPAR): Pedmarqsi, sodium thiosulfate, Date of authorisation: 26/05/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0